Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines

• Main Authors: Timo Vesikari (Author), Jin Xu (Author), David R. Johnson (Author), Jessie Hall (Author), Tomáš Marček (Author), Michelle G. Goveia (Author), Camilo J. Acosta (Author), Andrew Wen-Tseng Lee (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In randomized active-comparator controlled studies, DTaP5-HB-IPV-Hib showed comparable immunogenicity and safety to other licensed vaccines. This study assessed persistence of anti-hepatitis B surface antigen (HBs) and anti-pertussis antibodies, when children were 4 to 5 years of age, 3 to 4 years a...